{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:27:51Z","timestamp":1781846871618,"version":"3.54.5"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017481","name":"Ulusal Metroloji Enstit\u00fcs\u00fc, T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ftirma Kurumu","doi-asserted-by":"publisher","award":["114S261"],"award-info":[{"award-number":["114S261"]}],"id":[{"id":"10.13039\/501100017481","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-023-01588-x","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T11:41:38Z","timestamp":1677152498000},"page":"979-986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Propensity score-matched analysis of long-term outcomes for living kidney donation in alternative complement pathway diseases: a pilot study"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3816-8047","authenticated-orcid":false,"given":"Yasar","family":"Caliskan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda","family":"Safak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur Akin","family":"Oto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Velioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna","family":"Yelken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safak","family":"Mirioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Burak","family":"Dirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmecit","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurana","family":"Guller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alparslan","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydin","family":"Turkmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"issue":"2","key":"1588_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1053\/j.ajkd.2015.03.040","volume":"66","author":"M Noris","year":"2015","unstructured":"Noris M, Remuzzi G (2015) Glomerular diseases dependent on complement activation, including atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis, and C3 glomerulopathy: core curriculum 2015. Am J Kidney Dis 66(2):359\u2013375","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1588_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000479012","volume":"46","author":"Y Caliskan","year":"2017","unstructured":"Caliskan Y, Torun ES, Tiryaki TO, Oruc A, Ozluk Y, Akgul SU et al (2017) Immunosuppressive treatment in C3 glomerulopathy: is it really effective? Am J Nephrol 46(2):96\u2013107","journal-title":"Am J Nephrol"},{"key":"1588_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-022-01465-z","author":"JM Halimi","year":"2022","unstructured":"Halimi JM, Al-Dakkak I, Anokhina K, Ardissino G, Licht C, Lim WH et al (2022) Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry. J Nephrol. https:\/\/doi.org\/10.1007\/s40620-022-01465-z","journal-title":"J Nephrol"},{"issue":"23","key":"1588_CR4","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","volume":"341","author":"RA Wolfe","year":"1999","unstructured":"Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY et al (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341(23):1725\u20131730","journal-title":"N Engl J Med"},{"issue":"16","key":"1588_CR5","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1016\/j.molimm.2007.06.003","volume":"44","author":"TS Jokiranta","year":"2007","unstructured":"Jokiranta TS, Zipfel PF, Fremeaux-Bacchi V, Taylor CM, Goodship TJ, Noris M (2007) Where next with atypical hemolytic uremic syndrome? Mol Immunol 44(16):3889\u20133900","journal-title":"Mol Immunol"},{"issue":"8","key":"1588_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00108-018-0455-9","volume":"59","author":"M Knoop","year":"2018","unstructured":"Knoop M, Haller H, Menne J (2018) Human genetics in atypical hemolytic uremic syndrome-its role in diagnosis and treatment. Internist (Berl) 59(8):799\u2013804","journal-title":"Internist (Berl)"},{"key":"1588_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000527180","volume":"53","author":"OA Oto","year":"2022","unstructured":"Oto OA, Safak S, Mirioglu S, Yelken B, Velioglu A, Dirim AB et al (2022) Long-term outcomes of living-related kidney donation for alport syndrome spectrum: a propensity score-matched analysis. Am J Nephrol 53:1\u20138","journal-title":"Am J Nephrol"},{"issue":"6","key":"1588_CR8","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.1053\/ajkd.2002.36938","volume":"40","author":"RL Donne","year":"2002","unstructured":"Donne RL, Abbs I, Barany P, Elinder CG, Little M, Conlon P et al (2002) Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor. Am J Kidney Dis 40(6):E22","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"1588_CR9","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1681\/ASN.2019040331","volume":"30","author":"J Zuber","year":"2019","unstructured":"Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F et al (2019) Use of highly individualized complement blockade has revolutionized clinical outcomes after kidney transplantation and renal epidemiology of atypical hemolytic uremic syndrome. J Am Soc Nephrol 30(12):2449\u20132463","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"1588_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ki.2013.377","volume":"84","author":"MC Pickering","year":"2013","unstructured":"Pickering MC, D\u2019Agati VD, Nester CM, Smith RJ, Haas M, Appel GB et al (2013) C3 glomerulopathy: consensus report. Kidney Int 84(6):1079\u20131089","journal-title":"Kidney Int"},{"issue":"5","key":"1588_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424","journal-title":"Genet Med"},{"issue":"12","key":"1588_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010541","volume":"8","author":"BG Choi","year":"2019","unstructured":"Choi BG, Rha SW, Yoon SG, Choi CU, Lee MW, Kim SW (2019) Association of major adverse cardiac events up to 5 years in patients with chest pain without significant coronary artery disease in the Korean Population. J Am Heart Assoc 8(12):e010541","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"1588_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"issue":"17","key":"1588_CR14","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361(17):1676\u20131687","journal-title":"N Engl J Med"},{"issue":"1","key":"1588_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12882-020-01847-0","volume":"21","author":"S Kant","year":"2020","unstructured":"Kant S, Bhalla A, Alasfar S, Alachkar N (2020) Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome\u2014a single center experience. BMC Nephrol 21(1):189","journal-title":"BMC Nephrol"},{"issue":"3","key":"1588_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5527\/wjn.v2.i3.56","volume":"2","author":"M Salvadori","year":"2013","unstructured":"Salvadori M, Bertoni E (2013) Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations. World J Nephrol 2(3):56\u201376","journal-title":"World J Nephrol"},{"issue":"6","key":"1588_CR17","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.ekir.2021.03.885","volume":"6","author":"G Ardissino","year":"2021","unstructured":"Ardissino G, Longhi S, Porcaro L, Pintarelli G, Strumbo B, Capone V et al (2021) Risk of atypical HUS among family members of patients carrying complement regulatory gene abnormality. Kidney Int Rep 6(6):1614\u20131621","journal-title":"Kidney Int Rep"},{"key":"1588_CR18","doi-asserted-by":"crossref","unstructured":"Esparza-Gordillo J, Goicoechea de Jorge E, Buil A, Carreras Berges L, Lopez-Trascasa M, Sanchez-Corral P, et al (2005) Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet 14(5):703\u201312","DOI":"10.1093\/hmg\/ddi066"},{"issue":"2","key":"1588_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40472-021-00340-3","volume":"9","author":"Y Caliskan","year":"2022","unstructured":"Caliskan Y, Lee B, Whelan A, Abualrub F, Lentine KL, Jittirat A (2022) Evaluation of genetic kidney diseases in living donor kidney transplantation: towards precision genomic medicine in donor risk assessment. Curr Transplant Rep 9(2):127\u2013142","journal-title":"Curr Transplant Rep"},{"issue":"1","key":"1588_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/1744-9987.12763","volume":"23","author":"R Raina","year":"2019","unstructured":"Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L et al (2019) Atypical hemolytic-uremic syndrome: an update on pathophysiology, diagnosis, and treatment. Ther Apher Dial 23(1):4\u201321","journal-title":"Ther Apher Dial"},{"issue":"3","key":"1588_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2215\/CJN.09080817","volume":"13","author":"RS Avasare","year":"2018","unstructured":"Avasare RS, Canetta PA, Bomback AS, Marasa M, Caliskan Y, Ozluk Y et al (2018) Mycophenolate Mofetil in combination with steroids for treatment of C3 glomerulopathy: a case series. Clin J Am Soc Nephrol 13(3):406\u2013413","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"1588_CR22","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00467-022-05430-7","volume":"37","author":"Y Caliskan","year":"2022","unstructured":"Caliskan Y, Lentine KL (2022) Approach to genetic testing to optimize the safety of living donor transplantation in Alport syndrome spectrum. Pediatr Nephrol 37(9):1981\u20131994","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"1588_CR23","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1097\/00007890-199805270-00023","volume":"65","author":"D Ducloux","year":"1998","unstructured":"Ducloux D, Rebibou JM, Semhoun-Ducloux S, Jamali M, Fournier V, Bresson-Vautrin C et al (1998) Recurrence of hemolytic-uremic syndrome in renal transplant recipients: a meta-analysis. Transplantation 65(10):1405\u20131407","journal-title":"Transplantation"},{"issue":"5","key":"1588_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/00007890-197405000-00007","volume":"17","author":"J Bergstein","year":"1974","unstructured":"Bergstein J, Michael A Jr, Kellstrand C, Simmons R, Najarian J (1974) Hemolytic-uremic syndrome in adult sisters. Transplantation 17(5):487\u2013490","journal-title":"Transplantation"},{"key":"1588_CR25","doi-asserted-by":"crossref","unstructured":"Kaplan BS, Papadimitriou M, Brezin JH, Tomlanovich SJ, Zulkharnain (1997) Renal transplantation in adults with autosomal recessive inheritance of hemolytic uremic syndrome. Am J Kidney Dis 30(6):760-765","DOI":"10.1016\/S0272-6386(97)90079-2"},{"issue":"4","key":"1588_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/antib9040057","volume":"9","author":"M Revel","year":"2020","unstructured":"Revel M, Daugan MV, Sautes-Fridman C, Fridman WH, Roumenina LT (2020) Complement system: promoter or suppressor of cancer progression? Antibodies (Basel) 9(4):57","journal-title":"Antibodies (Basel)"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01588-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-023-01588-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01588-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:10Z","timestamp":1777564390000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/36\/4\/979\/8304786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["1588"],"URL":"https:\/\/doi.org\/10.1007\/s40620-023-01588-x","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"7 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethical Committee of Istanbul School of Medicine (approval number: 727087).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All living donors who could be reached during routine follow up visit were included in the study with written informed consent. For donors deceased during follow up, next of kin provided written informed consent for the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}